Steve Cummings
New England Journal of Medicine · 2000–2020
A researcher in the Science corpus: 24 papers; trusts 0 researchers and is trusted by 7 researchers here, as inferred from the citation graph.
Whom Steve Cummings trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Steve Cummings overall
Papers from Steve Cummings's perspective
Ordered by how strongly the researchers Steve Cummings trusts endorse each paper. Same corpus, a different order for every researcher.
- Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate (Journal of Bone and Mineral Research)
- The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women (Osteoporosis International)
- Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws (Annals of Internal Medicine)
- Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. (Journal of the American Medical Association (JAMA))
- Statistical validation of intermediate endpoints for chronic diseases.
- Relationship of subjective and objective social status with psychological and physiological functioning: preliminary data in healthy white women. (Health Psychology)
- Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. (Journal of the American Medical Association (JAMA))
- Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. (The journals of gerontology. Series A, Biological sciences and medical sciences)
- Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. (Archives of Internal Medicine)
- Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. (Journal of the American Medical Association (JAMA))
Their papers
- Denosumab for prevention of fractures in postmenopausal women with osteoporosis. (2009) — 2,981 citations
- Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. (2007) — 2,601 citations
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA (2020) — 1,145 citations
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo‐Controlled FREEDOM Trial and Its Extension (2018) — 626 citations
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. (2017) — 792 citations
- Sarcopenia With Limited Mobility: An International Consensus (2011) — 1,013 citations
- The Effect of 3 Versus 6 Years of Zoledronic Acid Treatment of Osteoporosis: A Randomized Extension to the HORIZON-Pivotal Fracture Trial (PFT) (2011) — 664 citations
- Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. (2009) — 785 citations
- Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. (2008) — 951 citations
- Calcium plus vitamin D supplementation and the risk of fractures. (2006) — 1,823 citations
- Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. (2006) — 1,433 citations
- Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. (2005) — 741 citations
- Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. (2004) — 655 citations
- Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. (2003) — 1,104 citations
- Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. (2003) — 1,259 citations
- BMD at Multiple Sites and Risk of Fracture of Multiple Types: Long‐Term Results From the Study of Osteoporotic Fractures (2003) — 1,044 citations
- Clinical use of bone densitometry: scientific review. (2002) — 828 citations
- Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. (2002) — 746 citations
- Older women with diabetes have a higher risk of falls: a prospective study. (2002) — 603 citations
- Epidemiology and outcomes of osteoporotic fractures. (2002) — 3,781 citations